OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
Michał Woźniak, Małgorzata Czyż
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6

Showing 6 citing articles:

Advances in Melanoma: From Genetic Insights to Therapeutic Innovations
Fernando Valdez-Salazar, Luis Alberto Jiménez-Del Río, Jorge Ramón Padilla‐Gutiérrez, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1851-1851
Open Access | Times Cited: 6

Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Michał Woźniak, Małgorzata Czyż
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access

Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat
Erin E. Resch, Stavriani C. Makri, Paola Ghanem, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access

Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation
Palmiro Poltronieri
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 841-876
Open Access | Times Cited: 1

RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma
Yanfang Jiang, Xintong Hu, Zhouyu Wang, et al.
Investigational New Drugs (2023) Vol. 42, Iss. 1, pp. 60-69
Closed Access | Times Cited: 2

Corynoxine exerts the anti-tumor effect on esophageal squamous cell carcinoma principally via the EZH2-DUSP5-ERK1/2-mediated cell growth inhibition
Gang Huang, Jiale Xu, Yingchao Li, et al.
Phytomedicine (2024) Vol. 135, pp. 156103-156103
Closed Access

Page 1

Scroll to top